Lower socioeconomic status was linked with worse eye structure and function at initial presentation in patients undergoing ...

Phase 1/2 clinical trial in Geographic Atrophy currently underway – – Kriya is developing KRIYA-825 as a potential one-time gene therapy, delivered by suprachoroidal injection, expressing a fusion ...

Topcon Healthcare acquired RetInSight, an Austria-based company that develops AI-driven software for eye care professionals, ...

Machine learning algorithms enhance retinopathy of prematurity screening using smartphone images, expanding access in ...

Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic ...

Q1 2025 Earnings Call Transcript May 7, 2025 EyePoint Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.65 EPS, expectations were $-0.65. Operator: Good morning. My ...

Subcutaneous administration generally safe and well-tolerated across multiple doses>80% reduction in anti-VEGF intravitreal injection burden in wet AMD and DME study eyes and >75% total reduction in ...

Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nutrients, waste and ...

LumiThera has released new topline data for its Valeda Light Delivery System to slow the progression of dry age-related ...

Bhavyateja Potineni's research highlights the transformative potential of AI-powered computer vision in medical imaging. By ...

UCL and Moorfields academics have launched a new medical technology company that aims to transform the detection and ...

CEO Jay Duker highlighted the progress of DURAVYU, their lead program for treating wet AMD, noting that over 90% of patients have been randomized in the LUGANO trial and over 50% in the LUCIA trial.